These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8635586)

  • 1. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
    Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
    FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
    Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
    Wells DE; Compans RW
    Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
    Bour S; Boulerice F; Wainberg MA
    J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.
    Otteken A; Earl PL; Moss B
    J Virol; 1996 Jun; 70(6):3407-15. PubMed ID: 8648672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
    Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
    Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
    Polydefkis M; Koenig S; Flexner C; Obah E; Gebo K; Chakrabarti S; Earl PL; Moss B; Siliciano RF
    J Exp Med; 1990 Mar; 171(3):875-87. PubMed ID: 1968506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.
    Kimura T; Nishikawa M; Ohyama A
    J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary structure of gp160 and gp120 envelope glycoproteins of human immunodeficiency virus type 1: a Fourier transform infrared spectroscopic study.
    Decroly E; Cornet B; Martin I; Ruysschaert JM; Vandenbranden M
    J Virol; 1993 Jun; 67(6):3552-60. PubMed ID: 8497064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160.
    Chander R; Schreier H
    Life Sci; 1992; 50(7):481-9. PubMed ID: 1371818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.
    Travis BM; Dykers TI; Hewgill D; Ledbetter J; Tsu TT; Hu SL; Lewis JB
    Virology; 1992 Jan; 186(1):313-7. PubMed ID: 1727607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of HIV envelope glycans.
    Fenouillet E; Gluckman JC; Jones IM
    Trends Biochem Sci; 1994 Feb; 19(2):65-70. PubMed ID: 8160267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.
    Nakamura GR; Byrn R; Rosenthal K; Porter JP; Hobbs MR; Riddle L; Eastman DJ; Dowbenko D; Gregory T; Fendly BM
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1875-85. PubMed ID: 1283308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.